Gainey McKenna & Egleston Announces It Has Filed An Action Against Teva Pharmaceutical Industries Limited

NEW YORK, July 20, 2017 -- Gainey McKenna & Egleston announces that it has filed a derivative action (and a class action in the alternative) against Teva Pharmaceutical Industries Limited in the United States District Court for the Southern District of Ohio (Western Division).  The action is brought on behalf of the Company’s Employee Stock Purchase Plan for U.S. Employees (“ESPP”), against certain Defendants to cover those persons who purchased or otherwise acquired Teva American Depository Shares (“ADSs”) between February 9, 2015 and November 3, 2016 (“Relevant Period”) in the ESPP.  The action brings claims under § 11 of the Securities Act of 1933 as well as claims under state law for breach of fiduciary duty, non-disclosure and breach of contract.

If you wish to serve as lead plaintiff, you must move the Court no later than September 18, 2017.  If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].